The latest research & treatment news about Hepatitis C infection, diagnosis, symptoms and treatment.

Previous

Did Tulsa Dentist Infect Nearly 60 Patients with Hep C?

Back to News Homepage

Next

Encouraging Trial Results for Hep C Drug Faldaprevir

Interferon-Free Study Boosts Belief in Sofosbuvir

April 25, 2013

Print this page

Sofosbuvir and ribavirin show a high response rate for Hepatitis C genotypes 2 and 3 in a Phase 3 study at Weil Cornell Medical Center.

New Hepatitis C Drug Continues Curing In Clinical Trials

As clinical trials continue to show positive results, sofosbuvir seems to be poised to gain FDA approval.

By Jonathan Weiss | Apr 24, 2013

Coming on the heels of a recent report indicating that the Hepatitis C drug sofosbuvir surpassed expectations, a Phase III clinical trial out of Weil Cornell Medical Center in New York City has shown that the result of using the drug cures most patients with two subtypes of the virus.

Continue reading this entire article:
http://www.medicaldaily.com/new-hepatitis-c-drug-continues-curing-clinical-trials-245236

No Comments - be the first!
Share
Share

Previous

Did Tulsa Dentist Infect Nearly 60 Patients with Hep C?

Back to News Homepage

Next

Encouraging Trial Results for Hep C Drug Faldaprevir

Requirements for using and reposting articles

Comments

HepatitisCentral.com provides information regarding hepatitis and liver disease. Comments are available to the community in order to discuss these topics and obtain answers to questions through community members. The Editors at HepatitisCentral.com will not be responding to questions or comments posed in article comments.